Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)15

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)10

Views

Views
November 20231
December 20231
January 20241
February 20241
March 20240
April 20242
May 20244
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views
Chicago2
Boardman2
Ashburn1